What is macrogenics inc macr about? MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The company generates its pipeline of product candidates from its proprietary suite of next-generation antibody-based technology platforms.When is the macrogenics mgc018 conference call? MacroGenics, Inc. Second Quarter 2021 Financial Results Conference Call Listen to webcast Jun 4 - Jun 8, 2021 ASCO 2021 Annual Meeting Supporting Materials Phase 1 Dose Escalation Study of MGC018, an anti-B7-H3 ADC In Patients with Advanced Solid Tumors549.4 KB Jun 4, 2021 4:30 PM EDT MacroGenics – MGC018 ASCO Conference CallWho is macrogenics general counsel? Jeffrey Peters, General Counsel, joined us in August 2015 as Vice President, Deputy General Counsel. Before joining MacroGenics, Mr. Peters most recently served as Deputy General Counsel, Health, for the Biotechnology Innovation Organization (BIO), the leading national trade association for the biotechnology industry.
Contact and general information about MacroGenics, Inc. company, headquarter location in Rockville, MD. Email formats & phone numbers of MacroGenics, Inc. ...